AAAAAA

   
Results: 1-25 | 26-50 | 51-68
Results: 1-25/68
ADSORPTION OF DIMETHYL METHYLPHOSPHONATE ON SELF-ASSEMBLED ALKANETHIOLATE MONOLAYERS
Authors: BERTILSSON L POTJEKAMLOTH K LIESS HD ENGQUIST I LIEDBERG B
Citation: L. Bertilsson et al., ADSORPTION OF DIMETHYL METHYLPHOSPHONATE ON SELF-ASSEMBLED ALKANETHIOLATE MONOLAYERS, JOURNAL OF PHYSICAL CHEMISTRY B, 102(7), 1998, pp. 1260-1269
1-HYDROXYLATION AND 3-HYDROXYLATION, IN ADDITION TO 4-HYDROXYLATION, OF DEBRISOQUINE ARE CATALYZED BY CYTOCHROME-P450 2D6 IN HUMANS
Authors: EIERMANN B EDLUND PO TJERNBERG A DALEN P DAHL ML BERTILSSON L
Citation: B. Eiermann et al., 1-HYDROXYLATION AND 3-HYDROXYLATION, IN ADDITION TO 4-HYDROXYLATION, OF DEBRISOQUINE ARE CATALYZED BY CYTOCHROME-P450 2D6 IN HUMANS, Drug metabolism and disposition, 26(11), 1998, pp. 1096-1101
CYP2C19 GENOTYPE AND PHENOTYPE DETERMINED WITH OMEPRAZOLE IN PATIENTSWITH ACID-RELATED DISORDERS WITH AND WITHOUT HELICOBACTER-PYLORI INFECTION
Authors: SAGAR M SEENSALU R TYBRING G DAHL ML BERTILSSON L
Citation: M. Sagar et al., CYP2C19 GENOTYPE AND PHENOTYPE DETERMINED WITH OMEPRAZOLE IN PATIENTSWITH ACID-RELATED DISORDERS WITH AND WITHOUT HELICOBACTER-PYLORI INFECTION, Scandinavian journal of gastroenterology, 33(10), 1998, pp. 1034-1038
INTERETHNIC DIFFERENCES IN THE CYP2D6 POLYMORPHISM WITH EMPHASIS ON GENE DUPLICATION AMPLIFICATION/
Authors: BERTILSSON L
Citation: L. Bertilsson, INTERETHNIC DIFFERENCES IN THE CYP2D6 POLYMORPHISM WITH EMPHASIS ON GENE DUPLICATION AMPLIFICATION/, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 35-35
THE EFFECT OF OMEPRAZOLE ON INTRAGASTRIC PH AND GASTRIN-LEVELS IS DETERMINED BY THE CYP2C19 POLYMORPHISM MORE THAN BY HELICOBACTER-PYLORI INFECTION IN PATIENTS WITH ACID-RELATED DISEASE
Authors: SAGAR M TYBRING G DAHL ML BERTILSSON L SEENSALU R
Citation: M. Sagar et al., THE EFFECT OF OMEPRAZOLE ON INTRAGASTRIC PH AND GASTRIN-LEVELS IS DETERMINED BY THE CYP2C19 POLYMORPHISM MORE THAN BY HELICOBACTER-PYLORI INFECTION IN PATIENTS WITH ACID-RELATED DISEASE, Gastroenterology, 114(4), 1998, pp. 1122-1122
METABOLISM OF ROPIVACAINE IN HUMANS IS MEDIATED BY CYP1A2 AND TO A MINOR EXTENT BY CYP3A4 - AN INTERACTION STUDY WITH FLUVOXAMINE AND KETOCONAZOLE AS IN-VIVO INHIBITORS
Authors: ARLANDER E EKSTROM G ALM C CARRILLO JA BIELENSTEIN M BOTTIGER Y BERTILSSON L GUSTAFSSON LL
Citation: E. Arlander et al., METABOLISM OF ROPIVACAINE IN HUMANS IS MEDIATED BY CYP1A2 AND TO A MINOR EXTENT BY CYP3A4 - AN INTERACTION STUDY WITH FLUVOXAMINE AND KETOCONAZOLE AS IN-VIVO INHIBITORS, Clinical pharmacology and therapeutics, 64(5), 1998, pp. 484-491
PHARMACOKINETICS OF NORTRIPTYLINE AND ITS 10-HYDROXY METABOLITE IN CHINESE SUBJECTS OF DIFFERENT CYP2D6 GENOTYPES
Authors: YUE QY ZHONG ZH TYBRING G DALEN P DAHL ML BERTILSSON L SJOQVIST F
Citation: Qy. Yue et al., PHARMACOKINETICS OF NORTRIPTYLINE AND ITS 10-HYDROXY METABOLITE IN CHINESE SUBJECTS OF DIFFERENT CYP2D6 GENOTYPES, Clinical pharmacology and therapeutics, 64(4), 1998, pp. 384-390
BANTU TANZANIANS HAVE A DECREASED CAPACITY TO METABOLIZE OMEPRAZOLE AND MEPHENYTOIN IN RELATION TO THEIR CYP2C19 GENOTYPE
Authors: HERRLIN K MASSELE AY JANDE M ALM C TYBRING G ABDI YA WENNERHOLM A JOHANSSON I DAHL ML BERTILSSON L GUSTAFSSON LL
Citation: K. Herrlin et al., BANTU TANZANIANS HAVE A DECREASED CAPACITY TO METABOLIZE OMEPRAZOLE AND MEPHENYTOIN IN RELATION TO THEIR CYP2C19 GENOTYPE, Clinical pharmacology and therapeutics, 64(4), 1998, pp. 391-401
CYP2D6 POLYMORPHISM IS NOT CRUCIAL FOR THE DISPOSITION OF SELEGILINE
Authors: SCHEININ H ANTTILA M DAHL ML KARNANI H NYMAN L TAAVITSAINEN P PELKONEN O BERTILSSON L
Citation: H. Scheinin et al., CYP2D6 POLYMORPHISM IS NOT CRUCIAL FOR THE DISPOSITION OF SELEGILINE, Clinical pharmacology and therapeutics, 64(4), 1998, pp. 402-411
ARTEMISININ INDUCES OMEPRAZOLE METABOLISM IN HUMAN-BEINGS
Authors: SVENSSON USH ASHTON M HAI TN BERTILSSON L HUONG DX VANHUONG N NIEU NT SY ND LYKKESFELDT J CONG LD
Citation: Ush. Svensson et al., ARTEMISININ INDUCES OMEPRAZOLE METABOLISM IN HUMAN-BEINGS, Clinical pharmacology and therapeutics, 64(2), 1998, pp. 160-167
INFLUENCE OF CYP2D6 POLYMORPHISM ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF TOLTERODINE
Authors: BRYNNE N DALEN P ALVAN G BERTILSSON L GABRIELSSON J
Citation: N. Brynne et al., INFLUENCE OF CYP2D6 POLYMORPHISM ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF TOLTERODINE, Clinical pharmacology and therapeutics, 63(5), 1998, pp. 529-539
10-HYDROXYLATION OF NORTRIPTYLINE IN WHITE PERSONS WITH 0-FUNCTIONAL,1-FUNCTIONAL, 2-FUNCTIONAL, 3-FUNCTIONAL, AND 13-FUNCTIONAL C-UPSILON-P2D6 GENES
Authors: DALEN P DAHL ML RUIZ MLB NORDIN J BERTILSSON L
Citation: P. Dalen et al., 10-HYDROXYLATION OF NORTRIPTYLINE IN WHITE PERSONS WITH 0-FUNCTIONAL,1-FUNCTIONAL, 2-FUNCTIONAL, 3-FUNCTIONAL, AND 13-FUNCTIONAL C-UPSILON-P2D6 GENES, Clinical pharmacology and therapeutics, 63(4), 1998, pp. 444-452
INTERACTION OF DIMETHYL METHYLPHOSPHONATE WITH ALKANETHIOLATE MONOLAYERS STUDIED BY TEMPERATURE-PROGRAMMED DESORPTION AND INFRARED-SPECTROSCOPY
Authors: BERTILSSON L ENGQUIST I LIEDBERG B
Citation: L. Bertilsson et al., INTERACTION OF DIMETHYL METHYLPHOSPHONATE WITH ALKANETHIOLATE MONOLAYERS STUDIED BY TEMPERATURE-PROGRAMMED DESORPTION AND INFRARED-SPECTROSCOPY, JOURNAL OF PHYSICAL CHEMISTRY B, 101(31), 1997, pp. 6021-6027
SIGNIFICANCE OF MONITORING PLASMA-LEVELS OF AMITRIPTYLINE, AND ITS HYDROXYLATED AND DESMETHYLATED METABOLITES IN PREDICTION OF THE CLINICALOUTCOME OF DEPRESSIVE STATE
Authors: SHIMODA K YASUDA S MORITA S SHIBASAKI M SOMEYA T BERTILSSON L TAKAHASHI S
Citation: K. Shimoda et al., SIGNIFICANCE OF MONITORING PLASMA-LEVELS OF AMITRIPTYLINE, AND ITS HYDROXYLATED AND DESMETHYLATED METABOLITES IN PREDICTION OF THE CLINICALOUTCOME OF DEPRESSIVE STATE, PSYCHIATRY AND CLINICAL NEUROSCIENCES, 51(1), 1997, pp. 35-41
IN-VITRO AND IN-VIVO STUDIES ON THE DISPOSITION OF MIRTAZAPINE IN HUMANS
Authors: DAHL ML VOORTMAN G ALM C ELWIN CE DELBRESSINE L VOS R BOGAARDS JJP BERTILSSON L
Citation: Ml. Dahl et al., IN-VITRO AND IN-VIVO STUDIES ON THE DISPOSITION OF MIRTAZAPINE IN HUMANS, Clinical drug investigation, 13(1), 1997, pp. 37-46
AN S-MEPHENYTOIN CYSTEINE CONJUGATE IDENTIFIED IN URINE OF EXTENSIVE BUT NOT OF POOR METABOLIZERS OF S-MEPHENYTOIN
Authors: TYRING G NORDIN J BERGMAN T BERTILSSON L
Citation: G. Tyring et al., AN S-MEPHENYTOIN CYSTEINE CONJUGATE IDENTIFIED IN URINE OF EXTENSIVE BUT NOT OF POOR METABOLIZERS OF S-MEPHENYTOIN, Pharmacogenetics, 7(5), 1997, pp. 355-360
CIBACRON-BLUE F3G-A ANCHORED MONOLAYERS WITH BIOSPECIFIC AFFINITY FORNAD(H)-DEPENDENT LACTATE-DEHYDROGENASE - CHARACTERIZATION BY FTIR-SPECTROSCOPY AND ATOMIC-FORCE MICROSCOPY
Authors: BERTILSSON L BUTT HJ NELLES G SCHLERETH DD
Citation: L. Bertilsson et al., CIBACRON-BLUE F3G-A ANCHORED MONOLAYERS WITH BIOSPECIFIC AFFINITY FORNAD(H)-DEPENDENT LACTATE-DEHYDROGENASE - CHARACTERIZATION BY FTIR-SPECTROSCOPY AND ATOMIC-FORCE MICROSCOPY, Biosensors & bioelectronics, 12(8), 1997, pp. 839-852
THE INVOLVEMENT OF CYP1A2 AND CYP3A4 IN THE METABOLISM OF CLOZAPINE
Authors: EIERMANN B ENGEL G JOHANSSON I ZANGER UM BERTILSSON L
Citation: B. Eiermann et al., THE INVOLVEMENT OF CYP1A2 AND CYP3A4 IN THE METABOLISM OF CLOZAPINE, British journal of clinical pharmacology, 44(5), 1997, pp. 439-446
CARBAMAZEPINE TREATMENT INDUCES THE CYP3A4 CATALYZED SULFOXIDATION OFOMEPRAZOLE, BUT HAS NO OR LESS EFFECT ON HYDROXYLATION VIA CYP2C19
Authors: BERTILSSON L TYBRING G WIDEN J CHANG M TOMSON T
Citation: L. Bertilsson et al., CARBAMAZEPINE TREATMENT INDUCES THE CYP3A4 CATALYZED SULFOXIDATION OFOMEPRAZOLE, BUT HAS NO OR LESS EFFECT ON HYDROXYLATION VIA CYP2C19, British journal of clinical pharmacology, 44(2), 1997, pp. 186-189
THE CYP2D6 GENOTYPE AND PLASMA-CONCENTRATIONS OF MIANSERIN ENANTIOMERS IN RELATION TO THERAPEUTIC RESPONSE TO MIANSERIN IN DEPRESSED JAPANESE PATIENTS
Authors: MIHARA K OTANI K TYBRING G DAHL ML BERTILSSON L KANEKO S
Citation: K. Mihara et al., THE CYP2D6 GENOTYPE AND PLASMA-CONCENTRATIONS OF MIANSERIN ENANTIOMERS IN RELATION TO THERAPEUTIC RESPONSE TO MIANSERIN IN DEPRESSED JAPANESE PATIENTS, Journal of clinical psychopharmacology, 17(6), 1997, pp. 467-471
CLOZAPINE METABOLISM IN-VITRO IS CATALYZED BY CYP1A2 AND CYP3A4
Authors: EIERMANN B ENGEL G BERTILSSON L
Citation: B. Eiermann et al., CLOZAPINE METABOLISM IN-VITRO IS CATALYZED BY CYP1A2 AND CYP3A4, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 460-460
INDIVIDUAL METABOLISM OF OMEPRAZOLE IS DETERMINED BY THE GENOTYPE OF THE ENZYME CYP2C19 WITHOUT RELATION TO HELICOBACTER-PYLORI INFECTION
Authors: SAGAR M BERTILSSON L DAHL ML TYBRING G SEENSALU R
Citation: M. Sagar et al., INDIVIDUAL METABOLISM OF OMEPRAZOLE IS DETERMINED BY THE GENOTYPE OF THE ENZYME CYP2C19 WITHOUT RELATION TO HELICOBACTER-PYLORI INFECTION, Gastroenterology, 112(4), 1997, pp. 275-275
INHIBITION OF THE SULFOXIDATION OF OMEPRAZOLE BY KETOCONAZOLE IN POORAND EXTENSIVE METABOLIZERS OF S-MEPHENYTOIN
Authors: BOTTIGER Y TYBRING G GOTHARSON E BERTILSSON L
Citation: Y. Bottiger et al., INHIBITION OF THE SULFOXIDATION OF OMEPRAZOLE BY KETOCONAZOLE IN POORAND EXTENSIVE METABOLIZERS OF S-MEPHENYTOIN, Clinical pharmacology and therapeutics, 62(4), 1997, pp. 384-391
ENANTIOSELECTIVE HYDROXYLATION OF OMEPRAZOLE CATALYZED BY CYP2C19 IN SWEDISH WHITE SUBJECTS
Authors: TYBRING G BOTTIGER Y WIDEN J BERTILSSON L
Citation: G. Tybring et al., ENANTIOSELECTIVE HYDROXYLATION OF OMEPRAZOLE CATALYZED BY CYP2C19 IN SWEDISH WHITE SUBJECTS, Clinical pharmacology and therapeutics, 62(2), 1997, pp. 129-137
PHARMACOGENETICS OF ANTIDEPRESSANTS - CLINICAL ASPECTS
Authors: BERTILSSON L DAHL ML TYBRING G
Citation: L. Bertilsson et al., PHARMACOGENETICS OF ANTIDEPRESSANTS - CLINICAL ASPECTS, Acta psychiatrica Scandinavica, 96, 1997, pp. 14-21
Risultati: 1-25 | 26-50 | 51-68